A recently engineered affibody conjugated to commercial microbubbles (MBABY‐B7‐H3) targeted against B7‐H3, a T‐cell modulator, was applied preclinically in breast cancer models for ultrasound molecular imaging.137. Here, CD276 is linked to breast carcinoma.